Company Overview of Itero Biopharmaceuticals, Inc.
As of August, 2011, Itero Biopharmaceuticals, Inc. went out of business. Itero Biopharmaceuticals, Inc. develops, manufactures and commercializes recombinant DNA-produced protein therapeutics. It provides recombinant follicle stimulating hormone for the treatment of female infertility. The company has a strategic partnership with Watson Pharmaceuticals, Inc. The company was founded in 2006 and is based in San Mateo, California. It has an additional location in Mountain View, California.
155 Bovet Road
San Mateo, CA 94402
Founded in 2006
Key Executives for Itero Biopharmaceuticals, Inc.
Itero Biopharmaceuticals, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Itero Biopharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.